Development code · Biologic
JNJ-63733657
JNJ-63733657 is a development code for Posdinemab, developed by Johnson & Johnson.
- Status
- Discontinued for Alzheimer's disease
- Mechanism
- Tau (pT217) Inhibitor
- Developer
- Johnson & Johnson
Programs
- Posdinemab for Alzheimer's diseaseDiscontinuedDiscontinued
Also known as
- Posdinemab
- 2517973-04-3